Single-agent tenofovir versus combination emtricitabine plus tenofovir for pre-exposure prophylaxis for HIV-1 acquisition: an update of data from a randomised, double-blind, phase 3 trial. Baeten JM et al, Lancet Infect Dis. 2014 Nov;14(11):1055-64 Posted on January 28th, 2015 - Pr François Raffi Predicting the outcomes of treatment to eradicate the latent reservoir for HIV-1. Hill AL et al, Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13475-80 Posted on January 19th, 2015 - Pr Pedro Cahn Back to Home page
Back to Home page